Search filters

List of works by Robert A Hauser

123IFP‐CIT (DaTscan) SPECT Brain Imaging in Patients with Suspected Parkinsonian Syndromes

scientific article published on March 16, 2011

A 500 U/2 mL dilution of abobotulinumtoxinA vs. placebo: randomized study in cervical dystonia

scientific article published on 17 January 2018

A double-blind placebo-controlled trial of zonisamide (zonegran) in the treatment of essential tremor

scientific article published in January 2007

A double-blind, delayed-start trial of rasagiline in Parkinson's disease

scientific article

A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes

scientific article

A novel design of a Phase III trial of isradipine in early Parkinson disease (STEADY-PD III).

scientific article

A pilot, double-blind, placebo-controlled trial of pregabalin (Lyrica) in the treatment of essential tremor

scientific article published in August 2007

A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit

scientific article published on May 2014

A randomized trial of a low-dose Rasagiline and Pramipexole combination (P2B001) in early Parkinson's disease.

scientific article published on 3 April 2017

A randomized trial of inhaled levodopa (CVT-301) for motor fluctuations in Parkinson's disease

scientific article published on 19 April 2016

A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): rationale, design, and baseline characteristics

scientific article

A(2A) Receptor Antagonism and Dyskinesia in Parkinson's Disease

scientific article

ADS-5102 (Amantadine) Extended Release for Levodopa-Induced Dyskinesia

scientific article published on 6 November 2017

ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study): A Randomized Clinical Trial

scientific article published on 12 June 2017

ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson's Disease (EASE LID 2 Study): Interim Results of an Open-Label Safety Study

scientific article published on 4 August 2017

AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study

scientific article

Adenosine A2A receptor antagonists for Parkinson's disease: rationale, therapeutic potential and clinical experience

scientific article

Advances in the pharmacologic management of early Parkinson disease

scientific article published on May 2007

Amantadine extended release for levodopa-induced dyskinesia in Parkinson's disease (EASED Study)

scientific article published on 04 February 2015

An update on Parkinson's disease: improving patient outcomes

scientific article published on January 2014

Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial

scientific article published on 12 December 2016

Association between Hoehn and Yahr, Mini-Mental State Examination, age, and clinical syndrome predominance and diagnostic effectiveness of ioflupane I 123 injection (DaTSCAN™) in subjects with clinically uncertain parkinsonian syndromes

scientific article

Autonomic Nervous System Dysfunction in Parkinson's Disease

scientific article published in March 2003

Botulinum toxin A for the treatment of cervical dystonia

scientific article published in September 2004

Caffeine and Progression of Parkinson Disease: A Deleterious Interaction With Creatine

scientific article

Caffeine and progression of Parkinson disease

scientific article

Caffeine, creatine, GRIN2A and Parkinson's disease progression

scientific article

Carbidopa levodopa enteral suspension

scientific article

Cardiovascular Safety of Droxidopa in Patients With Symptomatic Neurogenic Orthostatic Hypotension

scientific article published on 6 January 2017

Chorea as a side effect of gabapentin (Neurontin) in a patient with complex regional pain syndrome Type 1.

scientific article published on 16 October 2007

Chorea in a patient with cerebral palsy: treatment with levetiracetam

scientific article published in June 2005

Chorea induced by lamotrigine

scientific article published in April 2006

Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromes

scientific article published on March 13, 2013

Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials

scientific article

Clozapine withdrawal symptoms in a Parkinson's disease patient

scientific article published in November 2002

Cognitive function in 1736 participants in NINDS Exploratory Trials in PD Long-term Study-1.

scientific article published on 8 October 2016

Communicating with participants during the conduct of multi-center clinical trials

scientific article published on 29 August 2016

Conversion to carbidopa and levodopa extended-release (IPX066) followed by its extended use in patients previously taking controlled-release carbidopa-levodopa for advanced Parkinson's disease

scientific article

Crossover comparison of IPX066 and a standard levodopa formulation in advanced Parkinson's disease

scientific article published on 13 July 2011

Deep brain stimulation of the internal segment of the globus pallidus in delayed runaway dyskinesia

scientific article published on August 2006

Depression in Parkinson's disease

scientific article

Design of a cluster-randomized minority recruitment trial: RECRUIT.

scientific article published on 19 March 2017

Determination of minimal clinically important change in early and advanced Parkinson's disease

scientific article published on March 24, 2011

Diffuse Lewy Body Disease

scientific article published in November 2001

Double-blind study of pardoprunox, a new partial dopamine agonist, in early Parkinson's disease

scientific article

Double-blind study of the actively transported levodopa prodrug XP21279 in Parkinson's disease

scientific article published on 13 December 2013

Double-blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease

scientific article

Double-blind, randomized, controlled trial of rasagiline as monotherapy in early Parkinson's disease patients

scientific article

Droxidopa and Reduced Falls in a Trial of Parkinson Disease Patients With Neurogenic Orthostatic Hypotension

scientific article published on 21 June 2016

Droxidopa for the Short-Term Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Parkinson's Disease (nOH306B)

article

Droxidopa in patients with neurogenic orthostatic hypotension associated with Parkinson's disease (NOH306A).

scientific article published on January 2014

Duodenal levodopa infusion for the treatment of Parkinson's disease

scientific article published on April 2007

Early pharmacologic treatment in Parkinson's disease.

scientific article

Early treatment benefits of ropinirole prolonged release in Parkinson's disease patients with motor fluctuations

scientific article published on May 2010

Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial

scientific article

Effects of rasagiline on the progression of nonmotor scores of the MDS-UPDRS.

scientific article published on 27 December 2014

Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study

scientific article

Efficacy of rasagiline in early Parkinson's disease: a meta-analysis of data from the TEMPO and ADAGIO studies

scientific article

Efficacy, safety, and tolerability of overnight switching from immediate- to once daily extended-release pramipexole in early Parkinson's disease

scientific article published on October 2010

Essential tremor. Epidemiology, diagnosis, and treatment

scientific article published in September 2004

Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson's disease

scientific article

Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial

scientific article published on 26 February 2013

Factors associated with falling in early, treated Parkinson's disease: The NET-PD LS1 cohort

scientific article published on 11 April 2017

Fentanyl-induced bradykinesia and rigidity after deep brain stimulation in a patient with Parkinson disease.

scientific article published in January 2009

Future Treatments for Parkinson's Disease: Surfing the PD Pipeline

scientific article published on January 1, 2011

Future therapies for Parkinson's disease

scientific article published in October 2004

GCH1 in early-onset Parkinson's disease.

scientific article

Head injury, α-synuclein Rep1, and Parkinson's disease

scientific article published on January 2012

Help cure Parkinson's disease: please don't waste the Golden Year

scholarly article by Robert A Hauser published 2018 in NPJ Parkinson's disease

High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor.

scientific article published in September 1997

Identification of motor and nonmotor wearing-off in Parkinson's disease: comparison of a patient questionnaire versus a clinician assessment

scientific article published in June 2005

Individual-reader diagnostic performance and between-reader agreement in assessment of subjects with Parkinsonian syndrome or dementia using 123I-ioflupane injection (DaTscan) imaging

scientific article published on 12 June 2014

KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia

scientific article published on 21 March 2017

Leucine-rich repeat kinase 1: a paralog of LRRK2 and a candidate gene for Parkinson's disease

scientific article

Levetiracetam for stiff-person syndrome: report of 2 patients

scientific article published in September 2008

Levetiracetam for the treatment of essential tremor

scientific article

Levetiracetam for the treatment of generalized dystonia

scientific article published on 12 July 2005

Levetiracetam-induced parkinsonism in a Huntington disease patient

scientific article published in July 2005

Levodopa response in early Parkinson's disease

scientific article

Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: final 12-month, open-label results

scientific article

Levodopa-induced dyskinesia in Parkinson's disease: epidemiology, etiology, and treatment

scientific article published on July 2007

Levodopa-induced dyskinesias in Parkinson's disease: etiology, impact on quality of life, and treatments

scientific article published on 15 May 2008

Levodopa/carbidopa/entacapone 200/50/200 mg (Stalevo 200) in the treatment of Parkinson's disease: a case series

scientific article

Levodopa/carbidopa/entacapone in Parkinson's disease.

scientific article published in July 2009

Levodopa–carbidopa intestinal gel in advanced Parkinson's disease open-label study: Interim results

scientific article published on January 1, 2013

Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease

scientific article

Long-term effects of rasagiline and the natural history of treated Parkinson's disease

scientific article published in October 2016

Long-term efficacy of rasagiline in early Parkinson's disease

scientific article published on June 2010

Long-term evaluation of deep brain stimulation of the thalamus

scientific article

Long-term outcome of early versus delayed rasagiline treatment in early Parkinson's disease

scientific article

Long-term safety and efficacy of preladenant in subjects with fluctuating Parkinson's disease

scientific article published on 15 April 2013

Longer Duration of MAO-B Inhibitor Exposure is Associated with Less Clinical Decline in Parkinson's Disease: An Analysis of NET-PD LS1.

scientific article

Mavoglurant (AFQ056) in combination with increased levodopa dosages in Parkinson's disease patients

scientific article

Minimal clinically important difference in Parkinson's disease as assessed in pivotal trials of pramipexole extended release

scientific article published on April 2014

Mutant huntingtin is present in neuronal grafts in Huntington disease patients

scientific article published on 6 June 2014

NBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled study

scientific article

Neurogenic orthostatic hypotension and supine hypertension in Parkinson's disease and related synucleinopathies: prioritisation of treatment targets

scientific article published in August 2016

New considerations in the medical management of early Parkinson's disease: impact of recent clinical trials on treatment strategy

scientific article published on December 2009

Occupation and risk of parkinsonism: a multicenter case-control study

scientific article

Onset and duration of effect of extended-release carbidopa-levodopa in advanced Parkinson's disease.

scientific article

Onset of dyskinesia with adjunct ropinirole prolonged-release or additional levodopa in early Parkinson's disease

scientific article published on May 2010

Open-label pilot study of levetiracetam (Keppra) for the treatment of chorea in Huntington's disease

scientific article published in November 2006

Open-label pilot study of levetiracetam (Keppra) for the treatment of levodopa-induced dyskinesias in Parkinson's disease

scientific article published in September 2005

Optimizing bioavailability in the treatment of Parkinson's disease

scientific article published on 06 September 2007

Orally disintegrating selegiline in Parkinson patients with dopamine agonist-related adverse effects

scientific article published in January 2010

PROUD stands tall: delayed-start studies in Parkinson's disease

scientific article published on May 31, 2013

Pardoprunox in early Parkinson's disease: results from 2 large, randomized double-blind trials

scientific article published on 03 May 2011

Peptidoglycan recognition protein genes and risk of Parkinson's disease

scientific article

Pharmacokinetics of ADS-5102 (Amantadine) Extended Release Capsules Administered Once Daily at Bedtime for the Treatment of Dyskinesia.

scientific article

Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventions

scientific article

Predictors of Functional Decline in Early Parkinson's Disease: NET-PD LS1 Cohort

scientific article published on 26 November 2015

Pregabalin (Lyrica) in the treatment of essential tremor

scientific article published in January 2007

Preladenant as an Adjunctive Therapy With Levodopa in Parkinson Disease: Two Randomized Clinical Trials and Lessons Learned

scientific article

Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial

scientific article published on March 2011

Quantitative description of loss of clinical benefit following withdrawal of levodopa-carbidopa and bromocriptine in early Parkinson's disease

scientific article published in September 2002

Randomized controlled trial of deutetrabenazine for tardive dyskinesia: The ARM-TD study

scientific article

Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's disease

scientific article published on 5 September 2013

Randomized trial of cognitive speed of processing training in Parkinson disease

scientific article published on 06 September 2013

Randomized trial of preladenant, given as monotherapy, in patients with early Parkinson disease

scientific article published on 10 May 2017

Randomized trial of the adenosine A(2A) receptor antagonist istradefylline in advanced PD.

scientific article published in August 2003

Randomized trial of the triple monoamine reuptake inhibitor NS 2330 (tesofensine) in early Parkinson's disease

scientific article

Randomized, double-blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease

scientific article published on November 2010

Randomized, double-blind, pilot evaluation of intravenous glutathione in Parkinson's disease

scientific article published in May 2009

Randomized, placebo-controlled trial of ADS-5102 (amantadine) extended-release capsules for levodopa-induced dyskinesia in Parkinson's disease (EASE LID 3).

scientific article published on 21 August 2017

Randomized, placebo-controlled trial of trimethobenzamide to control nausea and vomiting during initiation and continued treatment with subcutaneous apomorphine injection

scientific article published on 27 August 2014

Rasagiline for mild cognitive impairment in Parkinson's disease: A placebo-controlled trial

scientific article published on 31 March 2016

Review: Improving symptom control in early Parkinson’s disease

scientific article published on November 1, 2009

Role of the pharmacist in the effective management of wearing-off in Parkinson's disease

scientific article published on 18 September 2007

Ropinirole therapy for Parkinson's disease

scientific article

Sleep attacks and dopamine agonists for Parkinson's disease: what is currently known?

scientific article

Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study

scientific article published in July 2003

Standing and Supine Blood Pressure Outcomes Associated With Droxidopa and Midodrine in Patients With Neurogenic Orthostatic Hypotension: A Bayesian Meta-analysis and Mixed Treatment Comparison of Randomized Trials

Study of istradefylline in patients with Parkinson's disease on levodopa with motor fluctuations

scientific article

Substantial improvement in a Meige's syndrome patient with levetiracetam treatment

scientific article published in December 2004

Tardive dyskinesia: Out of the shadows

scientific article published on 5 February 2018

Task force report on scales to assess dyskinesia in Parkinson's disease: critique and recommendations

scientific article published on July 2010

Tegaserod (Zelnorm) for the treatment of constipation in Parkinson's disease

scientific article

Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa

scientific article published in December 2007

The UPDRS-8: a brief clinical assessment scale for Parkinson's disease

scientific article published on 23 February 2012

The controversy concerning plasma homocysteine in Parkinson disease patients treated with levodopa alone or with entacapone: effects of vitamin status

scientific article published on May 2006

The independent influence of apathy and depression on cognitive functioning in Parkinson's disease

scientific article published in November 2010

The nosology of tardive syndromes

scientific article published on 6 February 2018

Therapeutic strategies for Parkinson disease: beyond dopaminergic drugs

scholarly article by Delphine Charvin et al published 12 October 2018 in Nature Reviews Drug Discovery

Tiagabine and exacerbation of essential tremor

scientific article published in October 2007

Topiramate as an adjunct to amantadine in the treatment of dyskinesia in parkinson's disease: A randomized, double-blind, placebo-controlled multicenter study

scientific article

Topiramate-induced psychosis in patients with essential tremor: report of 2 cases

scientific article published in May 2006

Tozadenant (SYN115) in patients with Parkinson's disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trial

scientific article published on 6 July 2014

Transplanted dopaminergic neurons develop PD pathologic changes: a second case report

scientific article published in December 2008

Treatment of chorea with levetiracetam

scientific article published in December 2005

Treatment of early Parkinson's disease. Part 1.

scientific article published on 29 January 2009

Treatment of early Parkinson's disease. Part 2.

scientific article published on 29 January 2009

Valbenazine for the treatment of tardive dyskinesia

scientific article

Vascular hemichorea/hemiballismus and topiramate

scientific article

Wearing-off scales in Parkinson's disease: critique and recommendations

scientific article published on 20 July 2011

Which dyskinesia scale best detects treatment response?

scientific article published on 6 February 2013

Zydis selegiline reduces off time in Parkinson's disease patients with motor fluctuations: a 3-month, randomized, placebo-controlled study

scientific article published in April 2004